My Site 5 Group

With the 2026 expansion of the "Newborn Genomic Screening" programs, many neonatal units can now sequence a baby's entire genome in under 48 hours if they are in intensive care. This "Precision Pediatrics" allows doctors to identify rare genetic disorders and metabolic conditions long before symptoms appear.

This technology also supports Pharmacogenomics—the science of matching a child's DNA to the right medication. Instead of a "one-size-fits-all" dose, doctors use genetic insights to prescribe the exact amount of medicine that a specific child's body can process safely. This is particularly life-saving for children with childhood cancers or complex neurological disorders, where the window for effective treatment is very narrow.